






OMPI, PRO, CLDX, DEST, AVNW, TESO Are Seasonally Ripe To Go Down In the Next Five Weeks
Published in Stocks and Investing on Tuesday, July 31st 2012 at 4:20 GMT by WOPRAI

July 31, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Obagi Medical Products Inc (NASDAQ:OMPI), Pershimco Resources Inc (NYSE:PRO), Celldex Therapeutics Inc (NASDAQ:CLDX), Destination Maternity Corp (NASDAQ:DEST), Aviat Networks Inc (NASDAQ:AVNW), TESCO Corp (NASDAQ:TESO) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date OMPI Obagi Medical Products Inc -3.50% 100.00% (5 of 5) Monday, August 6th 2012 PRO Pershimco Resources Inc -10.53% 100.00% (5 of 5) Monday, August 13th 2012 CLDX Celldex Therapeutics Inc -10.61% 100.00% (12 of 12) Wednesday, August 8th 2012 DEST Destination Maternity Corp -5.03% 91.67% (11 of 12) Monday, August 6th 2012 AVNW Aviat Networks Inc -8.54% 91.67% (11 of 12) Monday, August 6th 2012 TESO TESCO Corp -17.31% 90.91% (10 of 11) Tuesday, September 4th 2012Obagi Medical Products Inc (NASDAQ:OMPI) - Obagi Medical Products, Inc., a specialty pharmaceutical company, develops and markets topical aesthetic and therapeutic prescription skin care systems in the United States and internationally. It offers Obagi Nu-Derm System, which includes prescription and OTC drugs that are used for the treatment of fine lines, wrinkles, acne, photo-damage, hyperpigmentation, melasma, laxity, and skin sallowness; Obagi Condition and Enhance Systems that are used before and after surgical and non-surgical cosmetic procedures; Obagi-C Rx System, a combination of prescription, OTC drugs, and adjunctive cosmetic skin care products to treat skin conditions resulting from sun damage and the oxidative damage of free radicals; and Obagi Professional-C products, a line of proprietary, non-prescription products, which consist of vitamin C serums used to reduce the appearance of damage to the skin caused by ultraviolet radiation and other environmental influences. The company also provides ELASTIderm Eye and Decolletage, which increase the elasticity and skin tone of eyes, face, neckline, and chest; CLENZIderm M.D. Systems used for the treatment of acne; Obagi Rosaclear System used for the treatment of rosacea; Tretinoin used for the treatment of acne; Refissa used for the treatment of fine facial lines, hyperpigmentation, and tactile roughness; Metronidazole, an antibiotic used for the treatment of rosacea in the United States; and Obagi Blue Peel System used for the treatment of fine lines, wrinkles, and hyperpigmentation. In addition, it licenses certain non-prescription product concepts to Japanese based pharmaceutical companies for sale in Japan under the Obagi trademark. Obagi Medical Products, Inc. sells its products through own domestic sales force and foreign distributors to dermatologists, plastic surgeons, and other physicians that are focused on aesthetic and therapeutic skin care. The company was founded in 1988 and is headquartered in Long Beach, California.
Pershimco Resources Inc (NYSE:PRO) - PROS Holdings, Inc. provides pricing and margin optimization software worldwide. It offers PROS Pricing Solution Suite, which is a set of integrated software products that enables enterprises to apply pricing science to determine, analyze, and execute optimal pricing strategies. The companys software products support pricing decisions through the aggregation and analysis of enterprise application data, transactional data, and market information. Its PROS Pricing Solution Suite consists of Scientific Analytics, Price Optimizer, and Deal Optimizer. The Scientific Analytics software product provides visibility into pricing data and performance across the different segments of a business, which helps companies understand the pocket margin and its components, and locate detrimental pricing trends and underperforming segments of their businesses. The Price Optimizer software product help companies set and implement pricing policies throughout an enterprise and improve execution through pricing decision and negotiation support. The Deal Optimizer software product offers companies with pricing-related predictive analytics to optimize their pricing decision-making at the time of the sales transaction. The company also offers pricing and implementation professional services, as well as ongoing support and maintenance. PROS Holdings sells and markets its software products primarily through its direct sales force to customers in manufacturing, distribution, services, hotel and cruise, and airline industries. The company was founded in 1985 and is headquartered in Houston, Texas.
Celldex Therapeutics Inc (NASDAQ:CLDX) - Celldex Therapeutics, Inc., a biopharmaceutical company, engages in the development, manufacture, and commercialization of targeted immunotherapies that prevent or treat specific forms of cancer, autoimmune disorders, and diseases caused by infectious organisms. Its precision targeted immunotherapy platform includes a portfolio of monoclonal antibodies, antibody-targeted vaccines, antibody-drug conjugates, and immunomodulators to create disease-specific drug candidates. The company offers Rotarix for the treatment of rotavirus infection. Its clinical development programs include CDX-110, which is in Phase IIb clinical trail for the treatment of glioblastoma multiforme; CDX-011 that is in Phase II clinical trial to treat metastatic melanoma and breast cancer; and CDX-1307, a Phase I clinical trial product for treating colorectal, bladder, pancreas, ovarian, and breast tumors, as well as CDX-1401 and CDX-1135, which are in Phase I/II clinical trials for the treatment of multiple solid tumors and renal diseases respectively. The companys preclinical product candidates comprise CDX-301 for treating cancer, and autoimmune diseases and transplants; CDX-1127 for immuno-modulation and multiple tumors; CDX-014 to treat renal and ovarian cancer; and CDX-1189 for renal diseases. It has collaborative partnership agreements with GlaxoSmithKline plc; Pfizer Inc.; Vaccine Technologies, Inc.; and TopoTarget A/S, as well as research collaboration and licensing agreements with Medarex, Inc.; Alteris Therapeutics, Inc.; 3M Company; Amgen Inc.; Amgen Fremont; and Seattle Genetics, Inc. The company was founded in 1983 and is headquartered in Needham, Massachusetts.
Destination Maternity Corp (NASDAQ:DEST) - Destination Maternity Corporation engages in the design and retail of maternity apparel. The company offers casual and career wear, formal attire, lingerie, sportswear, and outerwear. As of September 30, 2010, the company operated 1,725 retail locations, including 698 stores in 50 states, Puerto Rico, Guam, and Canada; and 1,027 leased departments located within department stores and baby specialty stores throughout the United States. It operates stores under Motherhood Maternity, A Pea in the Pod, and Destination Maternity brand names. Motherhood Maternity brand serves the value-priced portion of the maternity apparel business with stores located in regional malls, strip and power centers, and central business districts. A Pea in the Pod brand serves the medium-priced portion and the luxury portion of the maternity apparel business with stores located in regional malls, lifestyle centers, central business districts, and certain stand-alone stores in affluent street locations. Destination Maternity brand carries Motherhood and Pea merchandise; and stores are located in regional malls and lifestyle centers. The company also sells its merchandise on the Web through its DestinationMaternity.com and brand-specific Web sites. In addition, Destination Maternity Corporation provides Two Hearts Maternity by Destination Maternity collection at approximately 600 Sears and Kmart locations throughout the U.S. through a leased department relationship. Further, the company distributes its Oh Baby by Motherhood collection through a licensed arrangement at Kohls stores in the U.S. and on Kohls.com. As of September 30, 2010, it had 31 international franchised locations, comprised of 8 stand-alone stores in the Middle East; and 23 shop-in-shop locations in India. The company was formerly known as Mothers Work, Inc. and changed its name to Destination Maternity Corporation in December 2008. The company was founded in 1980 and is headquartered in Philadelphia, Pennsylvania.
Aviat Networks Inc (NASDAQ:AVNW) - Aviat Networks, Inc. engages in the design, manufacture, and sale of a range of wireless networking products, solutions, and services worldwide. The company offers a product portfolio that addresses the needs of service providers and network operators addressing a range of applications, frequencies, capacities, and network topologies. Its product categories include 4G/WiMAX (fixed and mobile) broadband access, licensed and license-exempt point-to-point microwave radios, and element and network management software. The company offers broadband wireless access base stations and customer premises equipment based upon the IEEE 802.16d-2004 and 16e-2005 standards for fixed and mobile WiMAX; licensed point-to-point microwave radios that include Eclipse, a platform for nodal wireless transmission systems; TRuepoint, a platform for ultra-high capacity trunking applications; and Constellation, a family of medium-to-high-capacity point-to-point digital radios that operate in the 6, 7/8, and 10/11 GHz frequencies, which are designed for network applications and support both PDH and SONET. It also offers license-exempt wireless interconnection for wireless access, cellular backhaul, Internet service, local and wide area networking, and emergency response communications systems. In addition, the company provides NetBoss, a family of network management and service assurance solutions for managing multi-vendor, multi-technology communications networks; and ProVision, a centralized network monitoring and control system to manage wireless transmission networks. The company also offers professional services, including installation and commissioning and training. It serves mobile and fixed telephone service providers, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast system operators. Aviat Networks, Inc. is headquartered in Santa Clara, California.
TESCO Corp (NASDAQ:TESO) - Tesco Corporation engages in the design, manufacture, and service delivery of technology based solutions for the upstream energy industry worldwide. It operates in three segments: Top Drive Drilling Systems, Tubular Services, and CASING DRILLING. The Top Drive Drilling Systems segment manufactures, sells, and supports top drives that are used in drilling operations to rotate the drill string. Its product line includes a range of portable and permanently installed top drive products with lifting capacities of 150 through 750 tons, both hydraulically and electrically powered. This segment also provides hydraulically powered top drive systems for rent. The Tubular Services segment offers a range of tubular handling and installation services, including the TESCO Casing Drive System plus a range of downhole tool rentals and accessories. The CASING DRILLING segment provides downhole and surface equipment on a rental basis to allow a well to be drilled with conventional oilwell casing, eliminating the use of drill pipe. The company was founded in 1986 and is headquartered in Houston, Texas.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641